医学
经颈静脉肝内门体分流术
肝移植
内科学
门脉高压
队列
回顾性队列研究
胃肠病学
外科
肝硬化
移植
作者
Yael R. Nobel,Justin R. Boike,Nikhilesh R. Mazumder,Bartley Thornburg,Rachel S. Hoffman,K. Kolli,Marie Fallon,Jennifer C. Lai,Giuseppi Morelli,Erin K. Spengler,Adnan Said,Archita P. Desai,Sonali Paul,Aparna Goel,Kelly Hu,Catherine Frenette,Dyanna L. Gregory,Cynthia Padilla,Yuan Zhang,Lisa B. VanWagner,Elizabeth C. Verna
标识
DOI:10.1097/hep.0000000000001091
摘要
Background and Aims: While transjugular intrahepatic portosystemic shunt (TIPS) is traditionally considered a bridge to liver transplant (LT), some patients achieve long-term transplant-free survival (TFS) with TIPS alone. Prognosis and need for LT should not only be assessed at time of procedure, but also re-evaluated in patients with favorable early outcomes. Approach and Results: Adult TIPS recipients in the multicenter Advancing Liver Therapeutic Approaches retrospective cohort study were included (N=1,127 patients; 2,040 person-years follow-up). Adjusted competing risk regressions were used to assess factors associated with long-term post-TIPS clinical outcomes at time of procedure and at 6 months post-TIPS. MELD-Na at TIPS was significantly associated with post-TIPS mortality (sHR of death 1.1 [ p =0.42], 1.3 [ p =0.04], and 1.7 [ p <0.01] for MELD-Na 15-19, 20-24, and ≥25 relative to MELD-Na <15, respectively). MELD 3.0 was also associated with post-TIPS outcomes. Among the 694 (62%) patients who achieved early (6 mo) post-TIPS TFS, rates of long-term TFS were 88% at 1-year and 57% at 3-years post-TIPS. Additionally, a within-individual increase in MELD-Na score of >3 points from TIPS to 6 months post-TIPS was significantly associated with long-term mortality, regardless of initial MELD-Na score (sHR of death 1.8, p <0.01). For patients with long-term post-TIPS TFS, rates of complications of the TIPS or portal hypertension were low. Conclusions: Among patients with early post-TIPS TFS, prognosis and need for LT should be reassessed, informed by post-procedure changes in MELD-Na and clinical status. For selected patients, “destination TIPS” without LT may offer long-term survival with freedom from portal hypertensive complications.
科研通智能强力驱动
Strongly Powered by AbleSci AI